Publicaciones en las que colabora con Ramón Colomer Bosch (11)

2019

  1. BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

    Journal of Patient-Reported Outcomes, Vol. 3, Núm. 1

2010

  1. Current controversies in the management of breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286

  2. Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))

    Clinical and Translational Oncology

2009

  1. Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

    Breast Cancer Research and Treatment, Vol. 116, Núm. 2, pp. 351-358

  2. Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 727-736

2008

  1. A single-nucleotide polymorphismin the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma

    Clinical Cancer Research, Vol. 14, Núm. 3, pp. 811-816

  2. BRCA1 and acetyl-CoA carboxylase: The metabolic syndrome of breast cancer

    Molecular Carcinogenesis, Vol. 47, Núm. 2, pp. 157-163

2007

  1. Current controversies in the management of early breast cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 375-384

2001

  1. Circulating angiogenic growth factors as predictive factors in metastatic breast cancer treated with letrozole

    Breast Cancer Research and Treatment, Vol. 69, Núm. 3, pp. 244

  2. Serum HER-2 ECD and the efficacy of letrozole in ER+/ PR+ metastatic breast cancer: Preliminary results of a prospective study

    Breast Cancer Research and Treatment, Vol. 69, Núm. 3, pp. 242

2000

  1. Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial

    Seminars in Oncology, Vol. 27, Núm. 1 SUPPL. 1, pp. 20-24